[an error occurred while processing this directive]
Reviews

Recent progresses in molecular genetics of autism spectrum disorders

Expand
  • 1. State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China;
    2. College of Biological Sciences, China Agricultural University, Beijing 100193, China

Received date: 2015-06-17

  Revised date: 2015-07-24

  Online published: 2015-09-20

Abstract

Autism spectrum disorders (ASDs) are common neurodevelopmental disorders characterized by impaired social communication, restricted and repetitive behavior or interests. Over the past 40 years, the reported prevalence for ASDs has been steadily rising world-wide. Due to the application of large-scale exome sequencing in recent years, hundreds of novel ASD associated genes have been identified. These associated genes are enriched in several common genetic signaling pathways such as synapse formation and chromatin remodeling. Intensive studies in animal models have revealed abnormal synaptic plasticity and an imbalanced ratio of excitatory to inhibitory neurotransmission in neural circuits of ASD brains. In this review, we summarize recent advances in (1) genetic heterogeneity of ASDs, (2) molecular pathways disturbed by various genetic mutations in ASDs, and (3) the development of genetic diagnostics and pharmacological treatments for ASDs. This review aims to provide a brief overview of the genetic basis of ASDs and prospects for diagnosis and treatment for ASDs.

Cite this article

Hui Zhao, Yongchao Zhang, Yongqing Zhang . Recent progresses in molecular genetics of autism spectrum disorders[J]. Hereditas(Beijing), 2015 , 37(9) : 845 -854 . DOI: 10.16288/j.yczz.15-281

References

[1] American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 5th ed. Arlington: American Psychiatric Publishing, 2013.
[2] Autism and Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators. Prevalence of autism spectrum disorder among children aged 8 years autism and developmental disabilities monitoring network, 11 sites, United States, 2010 . MMWR , 2014, 63(2): 1-21.
[3] Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, Cheon KA, Kim SJ, Kim YK, Lee H, Song DH, Grinker RR. Prevalence of autism spectrum disorders in a total population sample . Am J Psychiatry , 2011, 168(9): 904-912.
[4] Wan YM, Hu Q, Li T, Jiang LJ, Du YS, Feng L, Wong JCM, Li CB. Prevalence of autism spectrum disorders among children in China: a systematic review . Shanghai Arch Psychiatry , 2013, 25(2): 70-80.
[5] Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology . Nat Rev Genet , 2008, 9(5): 341-355.
[6] Freitag CM. The genetics of autistic disorders and its clinical relevance: a review of the literature . Mol Psychiatry , 2007, 12(1): 2-22.
[7] Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, Lin CF, Stevens C, Wang LS, Makarov V, Polak P, Yoon S, Maguire J, Crawford EL, Campbell NG, Geller ET, Valladares O, Schafer C, Liu H, Zhao T, Cai GQ, Lihm J, Dannenfelser R, Jabado O, Peralta Z, Nagaswamy U, Muzny D, Reid JG, Newsham I, Wu YQ, Lewis L, Han Y, Voight BF, Lim E, Rossin E, Kirby A, Flannick J, Fromer M, Shakir K, Fennell T, Garimella K, Banks E, Poplin R, Gabriel S, DePristo M, Wimbish JR, Boone BE, Levy SE, Betancur C, Sunyaev S, Boerwinkle E, Buxbaum JD, Cook EH, Jr., Devlin B, Gibbs RA, Roeder K, Schellenberg GD, Sutcliffe JS, Daly MJ. Patterns and rates of exonic de novo mutations in autism spectrum disorders . Nature , 2012, 485(7397): 242-245.
[8] Berryer MH, Hamdan FF, Klitten LL, Møller RS, Carmant L, Schwartzentruber J, Patry L, Dobrzeniecka S, Rochefort D, Neugnot-Cerioli M, Lacaille JC, Niu Z, Eng CM, Yang YP, Palardy S, Belhumeur C, Rouleau GA, Tommerup N, Immken L, Beauchamp MH, Patel GS, Majewski J, Tarnopolsky MA, Scheffzek K, Hjalgrim H, Michaud JL, Di Cristo G. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency . Hum Mutat , 2013, 34(2): 385-394.
[9] O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, Levy R, Ko A, Lee C, Smith JD, Turner EH, Stanaway IB, Vernot B, Malig M, Baker C, Reilly B, Akey JM, Borenstein E, Rieder MJ, Nickerson DA, Bernier R, Shendure J, Eichler EE. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations . Nature , 2012, 485(7397): 246-250.
[10] Iossifov I, O'Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D, Stessman HA, Witherspoon KT, Vives L, Patterson KE, Smith JD, Paeper B, Nickerson DA, Dea J, Dong S, Gonzalez LE, Mandell JD, Mane SM, Murtha MT, Sullivan CA, Walker MF, Waqar Z, Wei LP, Willsey AJ, Yamrom B, Lee YH, Grabowska E, Dalkic E, Wang ZH, Marks S, Andrews P, Leotta A, Kendall J, Hakker I, Rosenbaum J, Ma BC, Rodgers L, Troge J, Narzisi G, Yoon S, Schatz MC, Ye K, McCombie WR, Shendure J, Eichler EE, State MW, Wigler M. The contribution of de novo coding mutations to autism spectrum disorder . Nature , 2014, 515(7526): 216-221.
[11] Jeste SS, Geschwind DH. Disentangling the heterogeneity of autism spectrum disorder through genetic findings . Nat Rev Neurol , 2014, 10(2): 74-81.
[12] Jiang YH, Ehlers MD. Modeling autism by SHANK gene mutations in mice . Neuron , 2013, 78(1): 8-27.
[13] Basu SN, Kollu R, Banerjee-Basu S. AutDB: a gene reference resource for autism research . Nucleic Acids Res , 2009, 37: D832-D836.
[14] Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J, Leotta A, Pai D, Zhang R, Lee YH, Hicks J, Spence
Outlines

/